Use of nitrite salts in chronic ischemia
View Patent ↗Methods of treating a subject who has chronic tissue ischemia are disclosed. The methods can include administering to the subject a pharmaceutical composition comprising inorganic nitrite or a pharmaceutically acceptable salt thereof, for a time and in an amount sufficient to result in blood vessel growth in the ischemic tissue. The subject can be diagnosed as having a medical condition that results in persistent or recurring restriction of blood supply to a tissue, for example, peripheral artery disease, diabetes, atherosclerotic cardiovascular disease or defective wound healing. The methods can include the step of identifying a suitable subject.
1. A method of treating peripheral neuropathy in a human subject, the method comprising: orally administering to the subject a pharmaceutical composition comprising about 5 mg to about 50 mg of sodium nitrite one to six times per day for at least ten days, thereby treating the peripheral neuropathy.
2. The method of claim 1 , further comprising a step of ceasing the administration of the pharmaceutical composition when a symptom of peripheral neuropathy in the subject improves.
3. The method of claim 2 , wherein the sodium nitrite is administered to a circulating nitrite concentration in the subject of about 0.01 M to about 0.6 M.
4. The method of claim 2 , wherein the method stimulates blood vessel growth in ischemic tissue but not in non-ischemic tissue.
5. The method of claim 4 , wherein the ischemic tissue comprises skeletal muscle, smooth muscle, cardiac muscle, neuronal tissue, skin, mesenchymal tissue, connective tissue, gastrointestinal tissue or bone.
6. The method of claim 5 , wherein administration of said sodium nitrite alters nitrite levels in the blood.
7. The method of claim 5 , wherein administration of said sodium nitrite raises nitrite levels in the ischemic tissue.
8. The method of claim 1 , wherein the sodium nitrite is administered two times per day.